DIRECT ORAL ANTICOAGULANTS FOR EXTENDED THROMBOPROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

Noman Lateef; Muhammad Shahzeb Khan; Safi U. Khan; Sagar Ranka; Abdul Mannan; Edo Kaluski; Venkata M. Alla

Journal ArticleOPEN ACCESS

DIRECT ORAL ANTICOAGULANTS FOR EXTENDED THROMBOPROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

Lateef N
Khan M
Khan S
et al.

Journal of the American College of Cardiology (2019) 73(9) 2109

DOI: 10.1016/s0735-1097(19)32715-9

N/ACitations

4Readers

Abstract

Acutely ill hospitalized patients are at high risk of venous thromboembolism (VTE) with the risk persisting even after hospital discharge. We conducted a meta-analysis to evaluate the safety and efficacy of extended- versus short-duration thromboprophylaxis in such patients. PubMed, MEDLINE, Scopus

Cite

CITATION STYLE

APA

Lateef, N., Khan, M. S., Khan, S. U., Ranka, S., Mannan, A., Kaluski, E., & Alla, V. M. (2019). DIRECT ORAL ANTICOAGULANTS FOR EXTENDED THROMBOPROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS. Journal of the American College of Cardiology, 73(9), 2109. https://doi.org/10.1016/s0735-1097(19)32715-9

DIRECT ORAL ANTICOAGULANTS FOR EXTENDED THROMBOPROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

Abstract

Cite

Register to see more suggestions